These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 329858)
21. Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine. Glazener CM; Kelly NJ; Hull MG Gynecol Endocrinol; 1987 Dec; 1(4):373-8. PubMed ID: 3140587 [TBL] [Abstract][Full Text] [Related]
22. Bromocriptine (Bromergon, Lek) in the management of premenstrual syndrome. Meden-Vrtovec H; Vujić D Clin Exp Obstet Gynecol; 1992; 19(4):242-8. PubMed ID: 1294345 [TBL] [Abstract][Full Text] [Related]
23. The psychobiology of premenstrual dysphoria: the role of prolactin. Carroll BJ; Steiner M Psychoneuroendocrinology; 1978 Apr; 3(2):171-80. PubMed ID: 568295 [No Abstract] [Full Text] [Related]
24. [Therapy of the premenstrual syndrome and especially of cyclic mastodynia with bromocriptine]. Hauser GA Ther Umsch; 1983 Jul; 40(7):604-9. PubMed ID: 6684802 [No Abstract] [Full Text] [Related]
25. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome. Vellacott ID; Shroff NE; Pearce MY; Stratford ME; Akbar FA Curr Med Res Opin; 1987; 10(7):450-6. PubMed ID: 3621990 [TBL] [Abstract][Full Text] [Related]
26. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo. Sampson GA Br J Psychiatry; 1979 Sep; 135():209-15. PubMed ID: 385093 [TBL] [Abstract][Full Text] [Related]
27. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study. Utian WH; Begg G; Vinik AI; Paul M; Shuman L Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946 [TBL] [Abstract][Full Text] [Related]
28. Premenstrual syndrome and spironolactone. Burnet RB; Radden HS; Easterbrook EG; McKinnon RA Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):366-8. PubMed ID: 1799355 [TBL] [Abstract][Full Text] [Related]
29. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. Freeman EW; Rickels K; Sondheimer SJ; Polansky M JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258 [TBL] [Abstract][Full Text] [Related]
30. Premenstrual syndrome in Cape Town. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid. Gunston KD S Afr Med J; 1986 Aug; 70(3):159-60. PubMed ID: 3526590 [TBL] [Abstract][Full Text] [Related]
31. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level. Parsanezhad ME; Alborzi S; Jahromi BN Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169 [TBL] [Abstract][Full Text] [Related]
32. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Thys-Jacobs S; Starkey P; Bernstein D; Tian J Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512 [TBL] [Abstract][Full Text] [Related]
34. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Maddocks S; Hahn P; Moller F; Reid RL Am J Obstet Gynecol; 1986 Mar; 154(3):573-81. PubMed ID: 3513587 [TBL] [Abstract][Full Text] [Related]
35. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo. Hammarbäck S; Bäckström T Acta Obstet Gynecol Scand; 1988; 67(2):159-66. PubMed ID: 3140572 [TBL] [Abstract][Full Text] [Related]
36. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome. Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644 [TBL] [Abstract][Full Text] [Related]
37. Hyperprolactinaemia and luteal insufficiency. Seppälä M; Ranta T; Hirvonen E Lancet; 1976 Jan; 1(7953):229-30. PubMed ID: 55535 [TBL] [Abstract][Full Text] [Related]
39. New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline. Moro M; Inada Y; Kojima M; Miyata H; Komatsu H; Torii R Eur J Pharmacol; 1999 Feb; 368(1):57-66. PubMed ID: 10096770 [TBL] [Abstract][Full Text] [Related]